longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Catalyst Pharma(CPRX.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Are KALV, GBTG, MDV, CPRX Obtaining Fair Deals for their Shareholders?

PR Newswire·Yesterday at 06:22
US
MDV
-0.27%
US
CPRX
-0.06%
US
KALV
+0.04%
PR Newswire·Yesterday at 06:22
US
MDV
-0.27%
US
CPRX
-0.06%
US
KALV
+0.04%

Angelini Buyout And Firdapse Settlement Reframe Catalyst Pharmaceuticals Story

Simplywall·05/17/2026 18:12
US
CPRX
-0.06%
Simplywall·05/17/2026 18:12
US
CPRX
-0.06%

02:56 ETAre CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?

prnewswire·05/12/2026 14:57
US
CPRX
-0.06%
US
UNF
-0.59%
US
ACR
-0.31%
prnewswire·05/12/2026 14:57
US
CPRX
-0.06%
US
UNF
-0.59%
US
ACR
-0.31%

Key deals this week: Roche, Bayer, eBay, Bullish, and more

businessinsider·05/11/2026 03:47
US
RHHVF
+0.05%
US
CPRX
-0.06%
US
EBAY
-0.17%
businessinsider·05/11/2026 03:47
US
RHHVF
+0.05%
US
CPRX
-0.06%
US
EBAY
-0.17%

Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX

MorningStar·05/10/2026 08:34
US
CPRX
-0.06%
MorningStar·05/10/2026 08:34
US
CPRX
-0.06%
© 2026 Longbridge|Disclaimer

Event Tracking

May11
Catalyst Pharma released FY2026 Q1 earnings on May 11 After-Market EST: Actual Revenue USD 149.39 M (Forecast USD 148.18 M), Actual EPS USD 0.5 (Forecast USD 0.456)
23:00
May7
Angelini Pharma Agrees to $4.1 Billion Acquisition of Catalyst Pharmaceuticals
06:22
May4
Catalyst Pharma to Release FY2026 Q1 Earnings on May 11 After-Market EST, Forecast Revenue USD 148.18 M, EPS USD 0.456
00:23
Apr27
Italian Pharma Exploring Acquisition of US Biotech Firm
16:05
Feb26
Catalyst Pharma released FY2025 Q4 earnings on February 25 After-Market EST, actual revenue USD 152.61 M (forecast USD 142.75 M), actual EPS USD 0.41 (forecast USD 0.344)
00:00
Catalyst Pharma released FY2025 annual earnings on February 25 After-Market (EST), actual revenue USD 588.99 M (forecast USD 579.13 M), actual EPS USD 1.68 (forecast USD 1.614)
00:00

Schedules & Filings

Schedules
Filings
May11
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 149.39 M, Net Income 63.73 M, EPS 0.5

Feb25
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 152.61 M, Net Income 52.7 M, EPS 0.41

Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 148.39 M, Net Income 52.78 M, EPS 0.4199

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More